Prevalence of low testosterone in aging men with benign prostatic hyperplasia: data from the Proscar Long-term Efficacy and Safety Study (PLESS)

Figures & data

Table 1. Baseline characteristics.

	n	Mean age ± SD(year)	Mean TT ± SD (ng/dl)	Mean BMI ± SD (kg/m^2)
Total population	299	63.4 ± 6.8	424.6 ± 154.3	27.4 ± 3.9
BMI <25 kg/m^2	78	65.2 ± 6.8	493.1 ± 159.3	23.1 ± 1.6
BMI ≥25 to <30 kg/m^2	160	63.0 ± 7.0	422.0 ± 152.9	27.3 ± 1.4
BMI ≥30 kg/m^2	61	62.1 ± 5.9	343.9 ± 105.7	33.3 ± 3.2

BMI = body mass index, SD = standard deviation, TT = serum total testosterone.

Figure 1. Prevalence of LT (baseline serum TT <300 ng/dl), by baseline BMI.